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The Iowa Department of Public Health (IDPH) offers the Opioid Update to share information 
about opioid use and Iowa’s efforts to address the national opioid epidemic. Please feel free to 
submit topics to Madeline Scherb at madeline.scherb@idph.iowa.gov. 
 
In this issue:  
 
• Provider Spotlight 
• Department Efforts 
• Opioid News 
 
 
Provider Spotlight 
 
IDPH is introducing readers to Opioid Treatment Programs (OTPs) serving the State of Iowa.  
First, here’s a little information on what an OTP is, as defined by SAMHSA: 
 
In the United States, the treatment of opioid dependence with medications is governed by 
the Certification of Opioid Treatment Programs, 42 Code of Federal Regulations (CFR) 8. 
This regulation created a system to accredit and certify opioid treatment programs 
dispensing Methadone for an opioid use disorder. SAMHSA’s Division of Pharmacologic 
Therapies (DPT), part of the SAMHSA Center for Substance Abuse Treatment (CSAT), 
oversees the certification of OTPs. OTPs must be certified by SAMHSA and accredited by 
an independent, SAMHSA-approved accrediting body to dispense opioid treatment 
medications. All OTPs also must be licensed by the state in which they operate and must 
register with the Drug Enforcement Administration (DEA), through a local DEA office. 
 
Cedar Rapids Treatment Center (CRTC) 
The Cedar Rapids Treatment Center (CRTC), opened to serve patients in May of 2014, and is 
committed to providing the latest in evidence-based treatment in the most cost-effective patient 
specific manner possible.  As an Opioid Treatment Provider, CRTC utilizes methadone 
maintenance to treat opioid use disorders, in addition to other forms of medication assisted 
treatment such as buprenorphine and naltrexone.  CRTC strives to provide comprehensive, 
medically monitored chemical dependency treatment services for persons with demonstrated 
opioid dependence, with the primary goal of assisting the persons served to achieve significant 
improvement in their quality of life through the reduction or elimination of their use of licit/illicit 
chemicals.     
CRTC is open Monday through Saturday.  Hours of operation are 6:00am to 2:30pm Monday 
through Friday, and 7:30am through 10:00am on Saturdays.  Admissions are completed on 
Tuesdays and Thursdays and walk-ins are welcome anytime during business hours to start the 
assessment process.  Applicants must be 18 years of age and must meet DSM criteria for an 
opioid use disorder. Patients also have access to a 24-hour telephone service if they need to 
contact staff after hours.   
 
CRTC is licensed as a treatment program by the Iowa Department of Public Health Division of 
Behavioral Health and certified by the Substance Abuse and Mental Health Services 
Administration (SAMSHA) under 21 CFR Part 291 and 42 CFR Part 8. In addition, CRTC was 
awarded a three (3) year accreditation from the Commission of the Accreditation of 
Rehabilitation Facilities (CARF).  For more information, please call 319-531-3824 or visit  
www.cedarrapidsctc.com. 
 
 
Department Efforts 
Prevention efforts: Prescription Drug Media Campaign 
The SPF Rx media campaign to help reduce the misuse of prescription drugs for ages 12-25 
began in early June, throughout Iowa on YouTube, banner ads, billboards, and Pandora. The 
video can be seen here https://youtu.be/u9rUDWmFNIk  
 
 
 
Opioid News  
Iowa part of probe into opioid pharmaceutical marketing and sales* 
State Attorney General Tom Miller has announced that his office is part of an ongoing multi-
state investigation into whether certain opioid manufacturers have unlawfully marketed and sold 
the powerful painkillers, according to an Iowa Department of Justice release.  
A bipartisan group of state attorneys general is investigating the role that prescription opioid 
manufacturers may have played in creating and prolonging the nation's opioid abuse epidemic, 
the release states.  
“We’re asking tough questions and we’re seeking solid evidence to help us understand how 
pharmaceutical companies have mass-marketed and sold these highly addictive pain 
medications, including claims they’ve made about their products,” Miller said. “These are 
prescription drugs that we know have helped fuel epidemic levels of addiction to opioids and 
heroin.” 
*This article was adapted from the Des Moines Register. To see the original, go here. 
 
Despite Increases in Medication Assisted Treatment for Youth, Disparities Persist* 
Amidst emerging recommendations calling for expanded access to pharmacotherapy for youth 
with opioid use disorder, medications may have been historically underutilized and disparities 
may exist by age, sex, and race/ethnicity. In this large, national retrospective cohort of over 
20,000 youth aged 13 to 25 years with opioid use disorder, medication receipt increased from 
2001 to 2014, but only 1 in 4 individuals received buprenorphine or naltrexone. Younger 
individuals, females, and black and Hispanic youth were less likely to receive a medication. 
*This article was adapted from JAMA Pediatrics. To see the original, go here.  
 
Librarians treating Overdoses* 
“She’s not a paramedic,” the guard, Sterling Davis, said later. “She’s just a teen-adult librarian 
— and saved six people since April. That’s a lot for a librarian.” 
Long viewed as guardians of safe spaces for children, library staff members have begun taking 
on the role of first responder in drug overdoses. In at least three major cities — Philadelphia, 
Denver and San Francisco — library employees now know, or are set to learn, how to use the 
drug naloxone, usually known by its brand name Narcan, to help reverse overdoses. 
Their training tracks with the disastrous national rise in opioid use and an apparent uptick of 
overdoses in libraries, which often serve as daytime havens for homeless people and hubs of 
services in impoverished communities. 
*This excerpt is from WGNO. To see the full article, go here. 
 
